The usage of curcumin has been extended to protect against diabetes by inhibiting the endothelial nitric oxide synthase and transforming growth factor beta 1 (TGF-β1) in the kidney of rats through inhibiting p300/CBP and, thus, the repression of NF-κB [182]. Here, NFKB1 is linked to diabetes mellitus.